Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation

BACKGROUND: In the recent ESC/EACTS guidelines, left atrial appendage (LAA) occlusion or exclusion in patients undergoing (thoracoscopic) atrial fibrillation (AF) ablation surgery is recommended. The Watchman device (WD, Boston Scientific, Minnesota) has proved to reduce the risk of thromboembolic e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Interv Cardiol
Main Authors: Vroomen, Mindy, Maesen, Bart, Luermans, Justin G., Crijns, Harry J., Maessen, Jos G., La Meir, Mark, Pison, Laurent
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6739757/
https://ncbi.nlm.nih.gov/pubmed/31772531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/4525084
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados